bausch health companies inc glp-1 receptor agonist medications drugs transforming obesity and diabetes care in San Antonio GLP-1 Agonists: A Comprehensive Overview

Dihexa vs Cerebrolysin: Cognitive Enhancement Peptide Comparison for Neuroprotection Research Executive Summary Dihexa and Cerebrolysin both target cognitive enhancement and neuroprotection, but they occupy fundamentally different positions on the evidence spectrum

Semaglutide has been proven to reduce cardiovascular events by 20%, demonstrating health benefits beyond weight loss

Targeting HDACs with design and activity of new HDACi as an anticancer strategy

It also appears to boost mental alertness

How one woman lost 145 pounds without GLP-1 medication Published 12:21 pm Friday, May 9, 2025 (BPT) At just 30 years old, Gabby weighed 299 pounds and was prediabetic